Maternal and Perinatal Outcomes in Pregnant Women With Comorbid Inflammatory Bowel Disease and Chronic Liver Disease

Documenti analoghi

• Editorial: Mitigating the Risk of Adverse Pregnancy Outcomes in Women With Inflammatory Bowel Disease and Chronic Liver Disease—Authors' Reply
  di: Jessica D. Lee, et al.
  Pubblicazione: (2025)
• Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?
  di: Konstantinos Papamichael, et al.
  Pubblicazione: (2024)
• Prescribing Inflammatory Bowel Disease Medications in Chronic Kidney Disease: A Practical Guide
  di: Lynna Chen, et al.
  Pubblicazione: (2025)
• Mild Endoscopic Disease Activity Is Associated With Adverse Outcomes Among Older Adults With Inflammatory Bowel Disease
  di: Catherine Z. Tang, et al.
  Pubblicazione: (2025)
• Editorial: Allostatic Load and Inflammatory Bowel Disease
  di: Jeli Mendoza, et al.
  Pubblicazione: (2024)